DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)

Information source: Liaoyang Central Hospital
Information obtained from ClinicalTrials.gov on February 07, 2013
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Apnea; Snoring

Intervention: Polidocanol Sclerotherapy (Drug)

Phase: Phase 1/Phase 2

Status: Not yet recruiting

Sponsored by: Liaoyang Central Hospital

Official(s) and/or principal investigator(s):
Youliang YIN, MB, Study Director

Overall contact:
Hongyan Chen, MB, Phone: +86-0419-3221423, Email: lychy2006@yahoo.com.cn

Summary

The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of pharynx for OSAS & SS,to reduce pharyngeal compliance.

Clinical Details

Official title: Preliminary Study on Submucous Sclerosis of Pharynges With 1% Polidocanol to Treat Obstructive Sleep Apnea (OSA) & Snoring Subjects (SS)

Study design: Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: apnea-hypopnea index (AHI)is on polysomnography(PSG),to compare AHIanterior and posterior treatment.

Secondary outcome: Arterial oxygen saturation (SaO2) and body mass index (BMI)will be measured on polysomnography

Detailed description: Polidocanol submucous sclerosis in the part of pharynges with 1% polidocanol injection. The injection should be in the retropharyngeal submucosa and lateral pharyngeal bands and lateral pharyngeal submucosa and in front submucosa of soft palate. The injection is multi-point,and each point injection is 0. 3~0. 5ml;the total quantity/each time is not more than 5ml. Every patient have to be treated about 1~2 time.

Eligibility

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- OSAS & SS which palatopharyngeal collapse.

Exclusion Criteria:

- obstructive sleep apnea syndrome (osas) & snoring subjects (ss),which anatomic narrow

result in.

Locations and Contacts

Hongyan Chen, MB, Phone: +86-0419-3221423, Email: lychy2006@yahoo.com.cn

Additional Information

Starting date: December 2006
Last updated: November 20, 2006

Page last updated: February 07, 2013

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012